Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis.

p63, a homologue of the tumor suppressor p53, is critical for the development and maintenance of squamous epithelia. p63 is specifically expressed in the basal layers of stratified epithelial tissues and is considered a specific marker for cells of this type. The role of p63 in tumorigenesis remains poorly defined. Numerous studies have highlighted the oncogenic potential of the predominant p63 isoform DeltaNp63alpha; however, data suggest that other p63 proteins can act as tumor suppressors or alter the metastatic potential of tumors. DeltaNp63alpha can act as a transcriptional repressor, but the link between the transcriptional functions of p63 and its biological role is still unclear. In this study, we used a loss-of-function approach to investigate the transcriptional programs controlled by p63. Disruption of p63 in squamous cell lines resulted in down-regulation of transcripts specifically expressed in squamous tissues and a significant alteration of keratinocyte differentiation. Interestingly, we found that disruption of p63 led to up-regulation of markers of nonepithelial tissues (mesenchyme and neural tissue) in both primary and immortalized squamous cells. Many of these up-regulated genes are associated with increased capacity for invasion and metastasis in tumors. Furthermore, loss of p63 expression was accompanied by a shift toward mesenchymal morphology and an increase in motility in primary keratinocytes and squamous cell lines. We conclude that loss of endogenous p63 expression results in up-regulation of genes associated with invasion and metastasis, and predisposes to a loss of epithelial and acquisition of mesenchymal characteristics. These findings have implications for the role of p63 in both development and tumorigenesis.

[1]  M. Nagayama,et al.  Downregulation of Wnt4 and upregulation of Wnt5a expression by epithelialmesenchymal transition in human squamous carcinoma cells , 2003, Cancer science.

[2]  H. Vogel,et al.  p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.

[3]  P. Hall,et al.  Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. , 2000, International journal of cancer.

[4]  Philip Lijnzaad,et al.  An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.

[5]  O. Ishikawa,et al.  Hyaluronan synthase 3 regulates hyaluronan synthesis in cultured human keratinocytes. , 2002, The Journal of investigative dermatology.

[6]  J. Capdevila,et al.  Epoxyeicosatrienoic Acids Activate Transglutaminases in Situ and Induce Cornification of Epidermal Keratinocytes* , 2003, Journal of Biological Chemistry.

[7]  C. Cordon-Cardo,et al.  p63 expression profiles in human normal and tumor tissues. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  M. Augustin,et al.  Cloning and chromosomal mapping of the human p53-related KET gene to Chromosome 3q27 and its murine homolog Ket to mouse Chromosome 16 , 1998, Mammalian Genome.

[9]  C. Cordon-Cardo,et al.  Loss of p63 expression is associated with tumor progression in bladder cancer. , 2002, The American journal of pathology.

[10]  P. Altevogt,et al.  L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers , 2005, The Journal of cell biology.

[11]  R. Hazan,et al.  Cadherin Switch in Tumor Progression , 2004, Annals of the New York Academy of Sciences.

[12]  Guojun Wu,et al.  DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. , 2005, Cancer research.

[13]  R. Dellavalle,et al.  CUSP/p63 expression in rat and human tissues. , 2001, Journal of dermatological science.

[14]  L. Ellisen,et al.  p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. , 2006, Cancer cell.

[15]  J. Pietenpol,et al.  p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent , 2000, Molecular and Cellular Biology.

[16]  S. Chi,et al.  Frequent alteration of p63 expression in human primary bladder carcinomas. , 2000, Cancer research.

[17]  D. Ponzin,et al.  p63 identifies keratinocyte stem cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Trink,et al.  p53 associates with and targets Delta Np63 into a protein degradation pathway. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[20]  J. Jen,et al.  Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma , 2000, International journal of cancer.

[21]  L. D. White,et al.  Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression. , 2006, Cancer research.

[22]  Y. Allory,et al.  The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  C. Arteaga,et al.  Autocrine Transforming Growth Factor-β Signaling Mediates Smad-independent Motility in Human Cancer Cells* , 2003, The Journal of Biological Chemistry.

[24]  Ming-Rong Wang,et al.  Elevated expression of p63 protein in human esophageal squamous cell carcinomas , 2002, International journal of cancer.

[25]  A. Yang,et al.  Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. , 2005, Cancer cell.

[26]  S. Nomoto,et al.  DeltaNp63 induces beta-catenin nuclear accumulation and signaling. , 2002, Cancer cell.

[27]  J. Pietenpol,et al.  Delta Np63 alpha expression is regulated by the phosphoinositide 3-kinase pathway. , 2003, The Journal of biological chemistry.

[28]  K. Kihara,et al.  Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  J. Jen,et al.  AIS is an oncogene amplified in squamous cell carcinoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[31]  D. Billheimer,et al.  IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium. , 2005, Cancer research.

[32]  J. Pietenpol,et al.  The ΔNp63α Phosphoprotein Binds the p21 and 14-3-3σ Promoters In Vivo and Has Transcriptional Repressor Activity That Is Reduced by Hay-Wells Syndrome-Derived Mutations , 2003, Molecular and Cellular Biology.

[33]  Guojun Wu,et al.  ΔNp63α Up-Regulates the Hsp70 Gene in Human Cancer , 2005, Cancer Research.

[34]  M. Hild,et al.  Zebrafish DeltaNp63 is a direct target of Bmp signaling and encodes a transcriptional repressor blocking neural specification in the ventral ectoderm. , 2002, Developmental cell.

[35]  Ryan M. Anderson,et al.  Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. , 2004, Cancer cell.

[36]  C. Bamberger,et al.  Identification and tissue distribution of novel KET/p63 splice variants , 2001, FEBS letters.

[37]  T. Tokino,et al.  deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. , 2003, Oncogene.

[38]  H. Brunner,et al.  The p63 gene in EEC and other syndromes , 2002, Journal of medical genetics.

[39]  U. Cavallaro N-cadherin as an invasion promoter: a novel target for antitumor therapy? , 2004, Current opinion in investigational drugs.

[40]  Chikashi Ishioka,et al.  Cloning and functional analysis of human p51, which structurally and functionally resembles p53 , 1998, Nature Medicine.

[41]  A. Mills,et al.  p63 is the molecular switch for initiation of an epithelial stratification program. , 2004, Genes & development.

[42]  P. Hainaut,et al.  TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe , 2001, British Journal of Cancer.

[43]  K. Tsai,et al.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage , 2002, Nature.

[44]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[45]  Yu Shyr,et al.  Significance of p63 amplification and overexpression in lung cancer development and prognosis. , 2003, Cancer research.

[46]  T. Tokino,et al.  ΔNp63α functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes , 2003, Oncogene.

[47]  P. Steinert,et al.  Bricks and mortar of the epidermal barrier , 1999, Experimental & Molecular Medicine.

[48]  X. Chen,et al.  The common and distinct target genes of the p53 family transcription factors , 2004, Cellular and Molecular Life Sciences CMLS.

[49]  D. Kimelman,et al.  A dominant-negative form of p63 is required for epidermal proliferation in zebrafish. , 2002, Developmental cell.

[50]  D. Billheimer,et al.  IGFBP-3 Is a Direct Target of Transcriptional Regulation by ΔNp63α in Squamous Epithelium , 2005 .

[51]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[52]  M. Schachner,et al.  Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. , 2002, European journal of cancer.

[53]  S. Nomoto,et al.  ΔNp63 induces β-catenin nuclear accumulation and signaling , 2002 .

[54]  S. Lowe,et al.  p63 deficiency activates a program of cellular senescence and leads to accelerated aging. , 2005, Genes & development.

[55]  B. Trink,et al.  p53 associates with and targets ΔNp63 into a protein degradation pathway , 2001 .

[56]  P. Hall,et al.  Characterization of the expression pattern of p63α and δnp63α in benign and malignant oral epithelial lesions , 2000 .

[57]  A. Yang,et al.  p63 and p73: p53 mimics, menaces and more , 2000, Nature Reviews Molecular Cell Biology.

[58]  J. Pietenpol,et al.  ΔNp63α Expression Is Regulated by the Phosphoinositide 3-Kinase Pathway* , 2003, Journal of Biological Chemistry.